Geneva/IBNS: The World Health Organisation (WHO) has informed that it is discontinuing the use of hydroxychloroquine and lopinavir/ritonavir arms in COVID-19 treatment for hospitalised patients as a part of its Solidarity Trial, stating the drugs had little effect on reducing the mortality rate.
Geneva: Investigations will continue into the effectiveness of hydroxychloroquine in treating COVID-19, , WHO chief Tedros Adhanom Ghebreyesus said.
London: A large observational study suggests that treatment with the antimalarial drug chloroquine or its analogue hydroxychloroquine (taken with or without the antibiotics azithromycin or clarithromycin) offers no benefit for patients with COVID-19. The study analysed data from nearly 15,000 patients with COVID-19 receiving a combination of any of the four drug regimens and 81,000 controls.
New York/IBNS: A large observational study suggests that treatment with the antimalarial drug chloroquine or its analogue hydroxychloroquine (taken with or without the antibiotics azithromycin or clarithromycin) offers no benefit for patients with COVID-19.
Washington/UNI: US President Donald Trump has said that he is taking hydroxychloroquine as a preventive measure against the novel coronavirus disease, even though it is not yet a proven treatment.
New York/IBNS: A study of nearly 1,400 patients with moderate to severe COVID-19 disease at a single New York hospital found that patients who received the drug fared no better than patients who did not receive the drug.
New Delhi/Columbus, Ohio/IBNS: The Supreme Court has admitted a Public Interest Litigation (PIL) filed by US-based Indian American doctor and patients' rights activist Kunal Saha on the use of Hydroxychloroquine (HCQ) and Azithromycin (AZM) in acutely ill COVID-19 patients.
Washington/Sputnik/UNI: The use of hydroxychloroquine with and without other medications has failed to reduce death rates from the coronavirus (COVID-19) and can actually cause fatalities, a study funded by the National Institutes of Health (NIH) and the University of Virginia said.
New Delhi/IBNS: The Indian Council of Medical Research(ICMR) on Saturday recommended hydroxychloroquine or HCQ as prophylaxis to prevent coronavirus infection instead of a treatment for COVID-19, said media reports.